4//SEC Filing
Garay Arpa 4
Accession 0001127602-22-013544
CIK 0000310158other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:24 PM ET
Size
10.7 KB
Accession
0001127602-22-013544
Insider Transaction Report
Form 4
Garay Arpa
SVP Human Health Global Mktg.
Transactions
- Tax Payment
Common Stock
2022-05-04$87.10/sh−259$22,559→ 2,109 total - Exercise/Conversion
Restricted Stock Unit
2022-05-04−907→ 1,819 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (907 underlying) - Exercise/Conversion
Common Stock
2022-05-04$87.10/sh+907$79,000→ 2,368 total - Award
Stock Option (Right to Buy)
2022-05-03+21,359→ 21,359 totalExercise: $87.10From: 2023-05-03Exp: 2032-05-02→ Common Stock (21,359 underlying)
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- [F4]The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001916360
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:24 PM ET
- Size
- 10.7 KB